GLP-1 drugs like Ozempic and Wegovy may slightly increase the risk of certain eye conditions and vision loss, but experts say that there's no reason to panic. According to two new studies published in the journal JAMA, patients with type 2 diabetes who take GLP-1s may face a modestly increased risk of diabetic retinopathy, but are still at decreased overall risk of life-threatening complications. The study authors recommended regular screening and monitoring to detect potential vision complications early.
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
